Markus Matilainen

1.4k total citations
50 papers, 1.0k citations indexed

About

Markus Matilainen is a scholar working on Pathology and Forensic Medicine, Surgery and Neurology. According to data from OpenAlex, Markus Matilainen has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 13 papers in Surgery and 12 papers in Neurology. Recurrent topics in Markus Matilainen's work include Multiple Sclerosis Research Studies (23 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and Orthopaedic implants and arthroplasty (11 papers). Markus Matilainen is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and Orthopaedic implants and arthroplasty (11 papers). Markus Matilainen collaborates with scholars based in Finland, Switzerland and United States. Markus Matilainen's co-authors include Laura Airas, Marjo Nylund, Eero Rissanen, Marcus Sucksdorff, Keijo Mäkelä, Antti Eskelinen, Jens Kühle, Jouni Tuisku, Pekka Pulkkinen and Klaus Nordhausen and has published in prestigious journals such as Nature Medicine, Brain and Neurology.

In The Last Decade

Markus Matilainen

46 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Matilainen Finland 17 383 357 161 153 134 50 1.0k
Regina Schlaeger Switzerland 14 465 1.2× 90 0.3× 176 1.1× 155 1.0× 57 0.4× 32 679
Feng Chang China 20 288 0.8× 395 1.1× 322 2.0× 28 0.2× 191 1.4× 61 1.3k
Masahito Hara Japan 16 387 1.0× 393 1.1× 148 0.9× 82 0.5× 134 1.0× 75 970
Friedrich Ihler Germany 21 62 0.2× 427 1.2× 102 0.6× 213 1.4× 167 1.2× 87 1.4k
Shengwen Liu China 16 151 0.4× 203 0.6× 148 0.9× 113 0.7× 175 1.3× 58 889
Aminul I. Ahmed United Kingdom 18 130 0.3× 113 0.3× 240 1.5× 34 0.2× 289 2.2× 35 897
Hooshang Saberi Iran 18 363 0.9× 274 0.8× 135 0.8× 43 0.3× 192 1.4× 70 1.0k
Simon Bayerl Germany 15 207 0.5× 306 0.9× 76 0.5× 57 0.4× 58 0.4× 47 658

Countries citing papers authored by Markus Matilainen

Since Specialization
Citations

This map shows the geographic impact of Markus Matilainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Matilainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Matilainen more than expected).

Fields of papers citing papers by Markus Matilainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Matilainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Matilainen. The network helps show where Markus Matilainen may publish in the future.

Co-authorship network of co-authors of Markus Matilainen

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Matilainen. A scholar is included among the top collaborators of Markus Matilainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Matilainen. Markus Matilainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saraste, Maija, Marjo Nylund, Markus Matilainen, et al.. (2025). Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 96(11). 1053–1060. 1 indexed citations
2.
Matilainen, Markus, Jouni Tuisku, Sauli Laaksonen, et al.. (2025). Synaptic Density in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 12(5). e200435–e200435.
3.
Klotz, Luisa, Joost Smolders, Markus Matilainen, et al.. (2025). Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis. Nature Medicine. 31(6). 2016–2026. 7 indexed citations
4.
Matilainen, Markus, et al.. (2024). Proximal humeral fractures in Finland: regional differences in incidence and methods of treatment. Journal of Shoulder and Elbow Surgery. 34(4). 1081–1087.
5.
Keller, Thomas H., Markus Matilainen, Jonathan J. Danon, et al.. (2024). Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA. EJNMMI Research. 14(1). 25–25. 4 indexed citations
6.
Saraste, Maija, Marjo Nylund, Rainer Hinz, et al.. (2024). Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals. Frontiers in Neurology. 15. 1352116–1352116. 6 indexed citations
7.
Saraste, Maija, Markus Matilainen, Marcus Sucksdorff, et al.. (2023). Association of serum neurofilament light with microglial activation in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 94(9). 698–706. 14 indexed citations
8.
Laaksonen, Sauli, Maija Saraste, Marcus Sucksdorff, et al.. (2023). Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis. Multiple Sclerosis and Related Disorders. 75. 104755–104755. 3 indexed citations
9.
Nylund, Marjo, et al.. (2023). Impact of natalizumab on chronic active lesions (P11-3.011). Neurology. 100(17_supplement_2). 1 indexed citations
10.
Dickens, Alex M., Markus Matilainen, Francisco R. Lopez‐Picon, et al.. (2022). Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation. EJNMMI Research. 12(1). 6–6. 9 indexed citations
11.
Saraste, Maija, Markus Matilainen, Cecília Rajda, et al.. (2022). Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 59. 103667–103667. 11 indexed citations
12.
Rissanen, Eero, Jouni Tuisku, Markus Matilainen, et al.. (2021). Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease. Parkinsonism & Related Disorders. 86. 40–44. 5 indexed citations
13.
Tuisku, Jouni, Markus Matilainen, Marjo Nylund, et al.. (2020). Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging. Neurology Neuroimmunology & Neuroinflammation. 7(3). 28 indexed citations
14.
Saraste, Maija, Marcus Sucksdorff, Virva Saunavaara, et al.. (2020). Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study. Multiple Sclerosis and Related Disorders. 48. 102690–102690. 4 indexed citations
15.
Airas, Laura, et al.. (2020). Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland. Multiple Sclerosis and Related Disorders. 40. 101980–101980. 20 indexed citations
16.
Laaksonen, Inari, Markus Matilainen, Antti Eskelinen, et al.. (2018). What Is the Long-term Survivorship of Cruciate-retaining TKA in the Finnish Registry?. Clinical Orthopaedics and Related Research. 476(6). 1205–1211. 14 indexed citations
17.
Matilainen, Markus, J.K. Miettinen, Klaus Nordhausen, Hannu Oja, & Sara Taskinen. (2017). On Independent Component Analysis with Stochastic Volatility Models. Austrian Journal of Statistics. 46(3-4). 57–66. 9 indexed citations
18.
Lempainen, Lasse, Markus Matilainen, Antti Eskelinen, et al.. (2017). Survival of uncemented cups from a single manufacturer implanted from 1985 to 2013: Finnish Arthroplasty Register data. Archives of Orthopaedic and Trauma Surgery. 137(3). 311–320. 4 indexed citations
19.
Mäkelä, Keijo, Markus Matilainen, Pekka Pulkkinen, et al.. (2014). Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ. 348(jan13 12). f7592–f7592. 136 indexed citations
20.
Junnila, Mika, Petri Virolainen, Ville Remes, et al.. (2013). Effect of femoral head size on risk of revision for dislocation after total hip arthroplasty. Acta Orthopaedica. 84(4). 342–347. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026